Cheryl Cohen to Influenza B virus
This is a "connection" page, showing publications Cheryl Cohen has written about Influenza B virus.
Connection Strength
1,895
-
Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study. Influenza Other Respir Viruses. 2016 07; 10(4):324-32.
Score: 0,514
-
Heterogeneity in influenza seasonality and vaccine effectiveness in Australia, Chile, New Zealand and South Africa: early estimates of the 2019 influenza season. Euro Surveill. 2019 Nov; 24(45).
Score: 0,166
-
The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century. PLoS One. 2019; 14(9):e0222381.
Score: 0,165
-
Household Transmission of Seasonal Influenza From HIV-Infected and HIV-Uninfected Individuals in South Africa, 2013-2014. J Infect Dis. 2019 04 19; 219(10):1605-1615.
Score: 0,160
-
Replacement of neuraminidase inhibitor-susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009-2013, South Africa. Influenza Other Respir Viruses. 2019 01; 13(1):54-63.
Score: 0,155
-
Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014. PLoS One. 2017; 12(5):e0177655.
Score: 0,141
-
Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015. Influenza Other Respir Viruses. 2017 03; 11(2):177-181.
Score: 0,136
-
Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination? PLoS One. 2016; 11(3):e0152310.
Score: 0,130
-
Effectiveness and knowledge, attitudes and practices of seasonal influenza vaccine in primary healthcare settings in South Africa, 2010-2013. Influenza Other Respir Viruses. 2015 May; 9(3):143-50.
Score: 0,122
-
Epidemiology of influenza virus types and subtypes in South Africa, 2009-2012. Emerg Infect Dis. 2014 Jul; 20(7):1162-9.
Score: 0,115
-
Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety. Clin Infect Dis. 2011 Jan 01; 52(1):128-37.
Score: 0,090